We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
PRA Group
PRAA
$685M
| $673K | ﹤0.01% |
20,484
| – | – |
|
1302
BioCryst Pharmaceuticals
BCRX
$2.44B
| $672K | ﹤0.01% |
53,360
+1,530
| +3% | +$19.7K |
|
1303
Check Point Software Technologies
CHKP
$14.2B
| $672K | ﹤0.01% |
6,000
+100
| +2% | +$12.1K |
|
1304
Doximity
DOCS
$3.92B
| $666K | ﹤0.01% |
+22,027
| New | +$807K |
|
1305
Extreme Networks
EXTR
$3.82B
| $666K | ﹤0.01% |
50,960
-9,490
| -16% | -$120K |
|
|
GMS
1306
DELISTED
GMS Inc
GMS
| $665K | ﹤0.01% |
16,610
| – | – |
|
1307
Steven Madden
SHOO
$3.16B
| $665K | ﹤0.01% |
24,944
-3,930
| -14% | -$124K |
|
1308
Coty
COTY
$2.41B
| $664K | ﹤0.01% |
105,130
-9,140
| -8% | -$69.1K |
|
1309
Trinity Industries
TRN
$2.99B
| $664K | ﹤0.01% |
31,100
| – | – |
|
1310
ArcBest
ARCB
$3.12B
| $663K | ﹤0.01% |
9,113
-680
| -7% | -$54.7K |
|
|
CVSA
1311
Covista Inc
CVSA
$4.51B
| $663K | ﹤0.01% |
18,192
-3,430
| -16% | -$131K |
|
|
KREF
1312
KKR Real Estate Finance Trust
KREF
$460M
| $661K | ﹤0.01% |
40,700
| – | – |
|
|
NOVA
1313
DELISTED
Sunnova Energy
NOVA
| $660K | ﹤0.01% |
29,910
+8,400
| +39% | +$204K |
|
1314
Aaon
AAON
$7.04B
| $658K | ﹤0.01% |
18,332
| – | – |
|
1315
O-I Glass
OI
$1.14B
| $657K | ﹤0.01% |
50,743
-11,080
| -18% | -$150K |
|
1316
Peloton Interactive
PTON
$2.87B
| $655K | ﹤0.01% |
94,450
-5,660
| -6% | -$57.5K |
|
1317
Strategic Education
STRA
$1.96B
| $655K | ﹤0.01% |
10,670
| – | – |
|
1318
Supernus Pharmaceuticals
SUPN
$2.73B
| $655K | ﹤0.01% |
19,346
| – | – |
|
1319
WSFS Financial
WSFS
$4.18B
| $655K | ﹤0.01% |
14,100
| – | – |
|
1320
Acadia Pharmaceuticals
ACAD
$4.46B
| $654K | ﹤0.01% |
40,000
-101,470
| -72% | -$1.64M |
|
1321
AeroVironment
AVAV
$7.32B
| $654K | ﹤0.01% |
7,850
-2,490
| -24% | -$223K |
|
1322
Beam Therapeutics
BEAM
$2.67B
| $654K | ﹤0.01% |
13,730
-60,757
| -82% | -$3.47M |
|
1323
Axos Financial
AX
$5.6B
| $653K | ﹤0.01% |
19,071
| – | – |
|
1324
SPX Corp
SPXC
$9.52B
| $653K | ﹤0.01% |
11,828
| – | – |
|
1325
United Parks & Resorts
PRKS
$2.18B
| $652K | ﹤0.01% |
14,330
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.